Prolific use of digital will change the game for medical devices, pharma and biotech companies – from how they innovate and design, conduct research, develop new treatments/devices and of course, engage with patients. Life Sciences (LS) companies are exploring not only digital tools that connect patient care needs, remote patient monitoring and data-driven insights — but also ways to accelerate research, create predictive capabilities, enable earlier interventions and contribute to proactive preventative care measures. Digital LS will quite literally change the future for patient health and life outcomes through combined science and technologies.